Anjali Nagpal

Anjali Nagpal is a Clinical Research Medical Director at Amgen since January 2024, bringing extensive experience from Biogen, where roles included Senior Director of R&D Portfolio Strategy and Director of Global Multiple Sclerosis Scientific Partnerships from March 2015 to October 2023. Anjali's earlier positions at Biogen involved leadership in Medical Information, Compliance, and Pharmacovigilance. Additional experience includes being a Clinical Research Physician at Eli Lilly and Company and a Consultant in Medical Training at Ranbaxy. Anjali holds a PhD in Medicine from The University of Adelaide and multiple medical degrees from Delhi University, as well as a Fellowship from the Royal College of Anesthetists in the UK.